| Year |
Citation |
Score |
| 2015 |
Akbarpour M, Goudy KS, Cantore A, Russo F, Sanvito F, Naldini L, Annoni A, Roncarolo MG. Insulin B chain 9-23 gene transfer to hepatocytes protects from type 1 diabetes by inducing Ag-specific FoxP3+ Tregs. Science Translational Medicine. 7: 289ra81. PMID 26019217 DOI: 10.1126/Scitranslmed.Aaa3032 |
0.595 |
|
| 2013 |
Annoni A, Cantore A, Della Valle P, Goudy K, Akbarpour M, Russo F, Bartolaccini S, D'Angelo A, Roncarolo MG, Naldini L. Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice. Embo Molecular Medicine. 5: 1684-97. PMID 24106222 DOI: 10.1002/Emmm.201302857 |
0.41 |
|
| 2013 |
Goudy K, Aydin D, Barzaghi F, Gambineri E, Vignoli M, Mannurita SC, Doglioni C, Ponzoni M, Cicalese MP, Assanelli A, Tommasini A, Brigida I, Dellepiane RM, Martino S, Olek S, et al. Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity Clinical Immunology. 146: 248-261. PMID 23416241 DOI: 10.1016/J.Clim.2013.01.004 |
0.625 |
|
| 2013 |
Annoni A, Goudy K, Akbarpour M, Naldini L, Roncarolo MG. Immune responses in liver-directed lentiviral gene therapy. Translational Research : the Journal of Laboratory and Clinical Medicine. 161: 230-40. PMID 23360745 DOI: 10.1016/J.Trsl.2012.12.018 |
0.344 |
|
| 2012 |
Gregori S, Goudy KS, Roncarolo MG. The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells. Frontiers in Immunology. 3: 30. PMID 22566914 DOI: 10.3389/Fimmu.2012.00030 |
0.492 |
|
| 2011 |
Goudy KS, Annoni A, Naldini L, Roncarolo MG. Manipulating Immune Tolerance with Micro-RNA Regulated Gene Therapy. Frontiers in Microbiology. 2: 221. PMID 22144977 DOI: 10.3389/Fmicb.2011.00221 |
0.435 |
|
| 2011 |
Mátrai J, Cantore A, Bartholomae CC, Annoni A, Wang W, Acosta-Sanchez A, Samara-Kuko E, De Waele L, Ma L, Genovese P, Damo M, Arens A, Goudy K, Nichols TC, von Kalle C, et al. Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic risk. Hepatology (Baltimore, Md.). 53: 1696-707. PMID 21520180 DOI: 10.1002/Hep.24230 |
0.4 |
|
| 2011 |
Goudy KS, Johnson MC, Garland A, Li C, Samulski RJ, Wang B, Tisch R. Reduced IL-2 expression in NOD mice leads to a temporal increase in CD62Llo FoxP3+ CD4+ T cells with limited suppressor activity. European Journal of Immunology. 41: 1480-90. PMID 21469091 DOI: 10.1002/Eji.201040890 |
0.728 |
|
| 2011 |
Goudy KS, Johnson MC, Garland A, Li C, Samulski RJ, Wang B, Tisch R. Inducible adeno-associated virus-mediated IL-2 gene therapy prevents autoimmune diabetes. Journal of Immunology (Baltimore, Md. : 1950). 186: 3779-86. PMID 21317396 DOI: 10.4049/Jimmunol.1001422 |
0.732 |
|
| 2010 |
Goudy K, Kenins L, Carballido J, Roncarolo M. Aryl Hydrocarbon Receptor Activation in Dendritic Cells by the Small Molecular Weight Compound (VAF347) Promotes FoxP3-expressing T Cell Differentiation Clinical Immunology. 135. DOI: 10.1016/J.Clim.2010.03.284 |
0.383 |
|
| 2009 |
Li C, Goudy K, Hirsch M, Asokan A, Fan Y, Alexander J, Sun J, Monahan P, Seiber D, Sidney J, Sette A, Tisch R, Frelinger J, Samulski RJ. Cellular immune response to cryptic epitopes during therapeutic gene transfer. Proceedings of the National Academy of Sciences of the United States of America. 106: 10770-4. PMID 19541644 DOI: 10.1073/Pnas.0902269106 |
0.622 |
|
| 2009 |
Li C, Hirsch M, DiPrimio N, Asokan A, Goudy K, Tisch R, Samulski RJ. Cytotoxic-T-lymphocyte-mediated elimination of target cells transduced with engineered adeno-associated virus type 2 vector in vivo. Journal of Virology. 83: 6817-24. PMID 19369348 DOI: 10.1128/Jvi.00278-09 |
0.671 |
|
| 2008 |
Goudy KS, Wang B, Tisch R. Gene gun-mediated DNA vaccination enhances antigen-specific immunotherapy at a late preclinical stage of type 1 diabetes in nonobese diabetic mice. Clinical Immunology (Orlando, Fla.). 129: 49-57. PMID 18675592 DOI: 10.1016/J.Clim.2008.06.001 |
0.757 |
|
| 2007 |
Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes. 56: 1395-402. PMID 17317763 DOI: 10.2337/Db06-0543 |
0.652 |
|
| 2007 |
Wong CP, Stevens R, Long B, Li L, Wang Y, Wallet MA, Goudy KS, Frelinger JA, Tisch R. Identical beta cell-specific CD8(+) T cell clonotypes typically reside in both peripheral blood lymphocyte and pancreatic islets. Journal of Immunology (Baltimore, Md. : 1950). 178: 1388-95. PMID 17237386 DOI: 10.4049/Jimmunol.178.3.1388 |
0.754 |
|
| 2005 |
Goudy KS, Tisch R. Immunotherapy for the prevention and treatment of type 1 diabetes. International Reviews of Immunology. 24: 307-26. PMID 16318984 DOI: 10.1080/08830180500379721 |
0.715 |
|
| 2003 |
Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA. Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. Journal of Immunology (Baltimore, Md. : 1950). 171: 2270-8. PMID 12928371 DOI: 10.4049/Jimmunol.171.5.2270 |
0.575 |
|
| 2003 |
Zhang YC, Pileggi A, Agarwal A, Molano RD, Powers M, Brusko T, Wasserfall C, Goudy K, Zahr E, Poggioli R, Scott-Jorgensen M, Campbell-Thompson M, Crawford JM, Nick H, Flotte T, et al. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. Diabetes. 52: 708-16. PMID 12606512 DOI: 10.2337/Diabetes.52.3.708 |
0.463 |
|
| Show low-probability matches. |